v3.26.1
Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses    
Research and development $ 384 $ 1,281
Selling, general and administrative 1,542 1,058
Total operating expenses 1,926 2,339
Loss from operations (1,926) (2,339)
Interest income 79 36
Net loss $ (1,847) $ (2,303)
Net loss per share of Common Stock, basic $ (0.48) $ (4.47)
Net loss per share of Common Stock, diluted $ (0.48) $ (4.47)
Weighted-average basic Common Stock 3,858,921 515,465
Weighted-average diluted Common Stock 3,858,921 515,465
Share-Based Payment Arrangement [Member]    
Operating expenses    
Research and development $ 14 $ 8
Selling, general and administrative $ 29 $ 29